The Mindful Media Project

April 4, 2022 updated by: Rebecca Segrave, Monash University

The Mindful Media Project: Can Mindfulness Meditation Reduce for Problematic Internet Use

Problematic Internet Use (PIU) is an emerging mental health issue. Research consistently shows that university students are disproportionately vulnerable to experiencing PIU, and that this can be linked with both poorer academic performance and mental health outcomes. Despite these adverse consequences, there has been no research to date on treatments for those experiencing PIU.

Preliminary research suggests that one promising candidate is mindfulness meditation. Mindfulness is a popular form of brain training that helps develop an ability to sit with uncomfortable thoughts and emotions, break compulsive behavioural patterns and make more mindful behavioural choices. The current proof-of-concept study aims to investigate the clinical potential of mindfulness meditation in reducing PIU severity for Australian university students who endorse moderate to severe PIU symptoms.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Problematic Use of the Internet (PUI) is an umbrella term encapsulating excessive and uncontrolled engagement with internet-related activities. PIU is increasingly recognised as an emerging mental health issue. It is characterised by a perceived loss of control over internet use despite repeated attempts to regulate it, and excessive internet-specific preoccupations or urges that result in distress and life impairment. Research consistently shows that university students are disproportionately vulnerable to experiencing PIU, and that this can be linked with both poorer academic performance and mental health outcomes.

Despite these adverse consequences, there has been no research to date on treatments for those experiencing PIU. Preliminary research suggests that one promising candidate for addressing PIU is mindfulness meditation. Mindfulness is a popular form of brain training that helps develop an ability to sit with uncomfortable thoughts and emotions, break compulsive behavioural patterns and make more mindful behavioural choices.

The current study is a proof of principal investigation. The primary aim is to evaluate the efficacy of a brief mindfulness meditation intervention for PIU among Australian university students who endorse moderate to severe PIU. The study will investigate a 30 day combination of daily meditation practice using the Headspace Inc supported by weekly online group meditation tuition. In order to support participant engagement in the meditation practices, a range of behaviour change techniques will be applied. A secondary is to evaluation the efficacy of these behaviour change techniques in support engagement.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Victoria
      • Melbourne, Victoria, Australia, 3800
        • Monash University, BrainPark

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Voluntary and able to provide informed consent
  • Endorse current moderate to severe PIU on IAT-10
  • Currently attending an Australian university (full-time or part-time, international or domestic student)
  • Ability to adhere to study procedures
  • If taking psychoactive medication, have been stable on same type and dose for at least 4 weeks prior to study commencement

Exclusion Criteria:

  • History of neurological illness or moderate to severe brain injury
  • Severely impaired visual/auditory ability
  • Diagnosed history of learning difficulty or other condition involving cognitive impairment as a primary feature.
  • Lack of both verbal and written fluency in English
  • Have engaged in > 10 instances of formal mindfulness meditation practice in past 12 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness Meditation
30-day program of mindfulness meditation comprising weekly group meditation tuition and support sessions and daily app-based mediation practice.

30-day mediation program comprising:

  1. Weekly group mediation tuition and support sessions delivered online. Sessions will last 45-60 minutes and focus on mindfulness meditation theory and techniques, and trouble shooting barriers to practice and engagement.
  2. 10-minutes of daily mindfulness meditation practice with the Headspace Inc app.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Problematic Internet Use (PIU) severity
Time Frame: Change from baseline PIU severity at 1 month (post-intervention).
10-item abbreviated Internet Addiction Test (IAT-10). Scores range from 10 to 50, with higher scores indicating increasing severity of PIU.
Change from baseline PIU severity at 1 month (post-intervention).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in response inhibition
Time Frame: Baseline (0 months), Post-Intervention (1 month), Follow-Up (2-months)
Stop Signal Task
Baseline (0 months), Post-Intervention (1 month), Follow-Up (2-months)
Change in psychological distress
Time Frame: Change from baseline psychological distress at 1 month (post-intervention) and 2 months (one-month follow-up post intervention).
The Depression Anxiety Stress Scale (DASS-21) consists of 21 items, 7 items per subscale: depression, anxiety and stress. For each subscale, scores can range from 0 to 42, with higher scores indicating greater severity or worse outcomes.
Change from baseline psychological distress at 1 month (post-intervention) and 2 months (one-month follow-up post intervention).
Change in experiential avoidance
Time Frame: Change from baseline experiential avoidance at 1 month (post-intervention) and 2 months (one-month follow-up post intervention).
The Brief Experiential Avoidance Questionnaire (BEAQ) is a 15-item short form of the Multidimensional Experiential Avoidance Questionnaire. Scores can range from 15 to 90, with higher scores indicating greater experiential avoidance.
Change from baseline experiential avoidance at 1 month (post-intervention) and 2 months (one-month follow-up post intervention).
Change in trait mindfulness
Time Frame: Change from baseline trait mindfulness at 1 month (post-intervention) and 2 months (one-month follow-up post intervention).
The Cognitive Affective Mindfulness Scale Revised (CAMS-R) is a 12-item scale, with scores ranging from 12 to 48. High scores indicate greater mindful qualities.
Change from baseline trait mindfulness at 1 month (post-intervention) and 2 months (one-month follow-up post intervention).
Change in psychological wellbeing
Time Frame: Change from baseline psychological wellbeing at 1 month (post-intervention) and 2 months (one-month follow-up post intervention).
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS) is a 14-item measure of psychological wellbeing, with scores ranging from 14 to 70. Higher scores indicate higher levels of mental wellbeing.
Change from baseline psychological wellbeing at 1 month (post-intervention) and 2 months (one-month follow-up post intervention).
Change in resilience
Time Frame: Change from baseline resilience at 1 month (post-intervention) and 2 months (one-month follow-up post intervention).
The Connor-Davidson Resilience Scale is a 10-item scale measuring resilience. Scores range from 0 to 40, and higher scores indicate higher resilience.
Change from baseline resilience at 1 month (post-intervention) and 2 months (one-month follow-up post intervention).
Change in social connectedness
Time Frame: Change from baseline social connectedness at 1 month (post-intervention) and 2 months (one-month follow-up post intervention).
The Campaign to End Loneliness Tool is a brief 3-item measure of social connectedness. Scores range from 0 to 12, and higher scores reflect greater social connectedness.
Change from baseline social connectedness at 1 month (post-intervention) and 2 months (one-month follow-up post intervention).
Number of participants retained in mindfulness intervention
Time Frame: Post-Intervention (1 month)
Number of participants who completed the intervention
Post-Intervention (1 month)
Engagement in intervention
Time Frame: Post-Intervention (1 month)
Number of meditation sessions completed
Post-Intervention (1 month)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 16, 2021

Primary Completion (Actual)

September 16, 2021

Study Completion (Actual)

December 30, 2021

Study Registration Dates

First Submitted

August 10, 2021

First Submitted That Met QC Criteria

November 28, 2021

First Posted (Actual)

December 1, 2021

Study Record Updates

Last Update Posted (Actual)

April 6, 2022

Last Update Submitted That Met QC Criteria

April 4, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 29159

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Problematic Internet Use

Clinical Trials on Mindfulness Meditation

Subscribe